Cardiovascular mortality after intensive LDL-Cholesterol lowering: Does baseline LDL-Cholesterol really matter?
It remains controversial whether reductions in cardiovascular mortality after intensive lowering of low density lipoprotein cholesterol (LDL-C) depend on baseline LDL-C levels. To reassess these findings, in this brief report, we performed an updated literature search through February 2020 and selec...
Main Authors: | Safi U. Khan, Erin D. Michos |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-03-01
|
Series: | American Journal of Preventive Cardiology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666667720300131 |
Similar Items
-
Quo vadis, LDL cholesterol?
by: Cobos Andrés, et al.
Published: (2023-05-01) -
Association Between Baseline, Achieved, and Reduction of CRP and Cardiovascular Outcomes After LDL Cholesterol Lowering with Statins or Ezetimibe: A Systematic Review and Meta‐Analysis
by: Xin‐Lin Zhang, et al.
Published: (2019-08-01) -
Is it need a criterion LDL cholesterol in definition of metabolic syndrome?
by: Yu. P. Nikitin, et al.
Published: (2014-03-01) -
Bempedoic Acid: A New Tool for LDL-Cholesterol Control in Patients with Coronary Artery Disease
by: Claudio Bilato, et al.
Published: (2022-04-01) -
Commentary: Involvement of LDL and ox-LDL in Cancer Development and Its Therapeutical Potential
by: Uffe Ravnskov, et al.
Published: (2022-05-01)